485 / 1195
ABMOS vs. Previous Model
*Criteria: 3%/2mm
Measured-Calculated Dose Agreement
Clinical
ABMOS
Prostate:
91.4%
±
4.1% 98.2%
±
1.6%
(25 patients, 175 beams)
Spine SBRT:
77.1%
±
9.7% 96.4%
±
2.8%
(25 patients, 214 beams)
|
|
485 / 1195
ABMOS vs. Previous Model
*Criteria: 3%/2mm
Measured-Calculated Dose Agreement
Clinical
ABMOS
Prostate:
91.4%
±
4.1% 98.2%
±
1.6%
(25 patients, 175 beams)
Spine SBRT:
77.1%
±
9.7% 96.4%
±
2.8%
(25 patients, 214 beams)